Search by Drug Name or NDC

    NDC 60505-4033-01 Icosapent Ethyl 1 g/1 Details

    Icosapent Ethyl 1 g/1

    Icosapent Ethyl is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Apotex Corp. The primary component is ICOSAPENT ETHYL.

    Product Information

    NDC 60505-4033
    Product ID 60505-4033_934f92b6-6be7-6fd4-cc64-8dd575526863
    Associated GPIs 39500035100120
    GCN Sequence Number 069960
    GCN Sequence Number Description icosapent ethyl CAPSULE 1 G ORAL
    HIC3 M4E
    HIC3 Description LIPOTROPICS
    GCN 33238
    HICL Sequence Number 039613
    HICL Sequence Number Description ICOSAPENT ETHYL
    Brand/Generic Generic
    Proprietary Name Icosapent Ethyl
    Proprietary Name Suffix n/a
    Non-Proprietary Name Icosapent Ethyl
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form CAPSULE
    Route ORAL
    Active Ingredient Strength 1
    Active Ingredient Units g/1
    Substance Name ICOSAPENT ETHYL
    Labeler Name Apotex Corp
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA209437
    Listing Certified Through 2024-12-31

    Package

    NDC 60505-4033-01 (60505403301)

    NDC Package Code 60505-4033-1
    Billing NDC 60505403301
    Package 120 CAPSULE in 1 BOTTLE (60505-4033-1)
    Marketing Start Date 2021-12-16
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 1.20861
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ICOSAPENT ETHYL 1 GRAM CAPSULE
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis